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Abstract - Apoptosis cell is one of the main biomolecular predictors to determine kind of treatment given to patient with colorectal 
cancer and to predict the end result. Phyllanthus niruri Linn (P. niruri L) acts as antineoplastic but its potency on the process of cancer 
cell apoptosis has not been revealed yet. The objective of the research was to evaluate the apoptosis index of rats with colorectal cancer 
treated with and without P. niruri L. extract. This research used The Randomized Posttest-Only Control Group Design. As many as 30 male 
Sprague-Dawley rats were induced with 1,2 DMH 30 mg/kgBW once in every week. Four rats were sacrificed at week 9th, 11th and 13th to 
be observed the development of colorectal cancer. Induction was then stopped and other 18 rats were randomly located into two groups. 
The first group was positive control (K+) group consisted of 9 rats without P. niruri extract. The second group (X) was consisted of 9 rats 
with the application of P.niruri L. extract 13.5 mg/kg per day orally. All rats were terminated on week 19th, tumor lesion was proceed for 
Histopathology preparations and stained with Kit TUNEL-IHC (Apo-BrdU-IHCTM BioVision Cat #K403) to identify the apoptosis cell. Data were 
analyzed using unpaired t-test with significant level of p<0.05. The result showed that the average of apoptosis index of X treatment was 2.37 + 
0.48 higher than K+ treatment namely 1.45 + 0.41 with a highly significance difference (p=0.000). Phyllanthus niruri L extract increased 
the apoptosis of colorectal cancer of Sprague-Dawley rats induced with 1,2 Dimethylhidrazine. 
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I. INTRODUCTION 
The incidence of colorectal cancer still marks high 
number until today. More than one million people per year 
worldwide are diagnosed with colorectal cancer and this 
malignancy is the fourth leading cancer causes death 
(Courtney et al., 2013). American Cancer Society stated that 
in 2008 there were 1,2 million cases of colorectal cancer 
worldwide (Society American Cancer, 2011). It was 
estimated that about 134.000 new cases with 55.000 deaths 
per year and this colorectal cancer caused almost 15% deaths 
due to cancer (Kumar et al., 2012). The number of colon and 
rectum cancer incidence as well as the deaths number in 
Indonesia are also still high. Colorectal cancer is the third 
largest kind of cancer in Indonesia with a total of 1,8 
cases/100.000 population and this number is predicted to 
increase along with lifestyle change of Indonesia people 
(Dharmais Hospital, 2009). This cancer mostly affects 
younga ge people with the same incidence comparison on 
male and female (Sjamsuhidajat, 2002). 
1,2 Dimethylhidrazine (DMH) is a potential carcinogen 
for colon and rectum causing mutations on the cells located 
at the bottom of the crypts. During migration to the lumen 
surface, cells experiencing mutations will spread along the 
crypts axis. Colon tissue tries to protect them by triggering 
the death of the cells in those areas to eliminate cells that 
could potentially mutate. There might be mutated cells keep 
survive which at the end they become transformed cells and 
then migrate into crypt lumen and lead to uncontrolled 
proliferation, cells accumulation and finally form tumor. 
Tumor development at colon and rectum associates with cell 
growth dysregulation and gradual apoptosis inhibitory as in 
this condition causes tremendous consequence in tumor 
genesis. This phenomenon indicates that apoptosis is an 
adaptive responds against the damage triggered by 1,2 DMH 
Internat. J. Sci. Eng., Vol. 10(1)2014:45-50, January 2016, Endang  Sawitri 
46 
© IJSE – ISSN: 2086-5023, 15th  January, 2016, All rights reserved 
and tumor will grow very quick if cells loss apoptosis ability 
(Watson, 2006; Samantha et al., 2008; Yang et al., 2009).  
Apoptosis is a specific process leading to cell death in a 
specific mechanism through activation of intracellular 
pathways that causes cellular change. A process on 
neoplastic transformation, progression and metastatic 
involves a normal apoptosis pathways change (Reed, 2003; 
Watson, 2004).  It seems that in the early neoplastic 
progression, tumor cells become more sensitive to agents that 
induce apoptosis. Meanwhile, progressive cells will 
resistance to apoptosis stimulation. Therefore, the majority of 
chemotherapy agents or radiation uses apoptosis pathways to 
induce death of cancer cells. The changes on the balance 
between proliferation and apoptosis become the principal of 
neoplastic changes. Multiple genetic defect accumulation 
interfering normal growth control, differentiation and 
apoptosis pathways becomes the principle on the 
development of colorectal cancer (Koornstra et al., 2003; 
Watson, 2006). Detection on apoptosis body which expressed 
by cancer cells can be done by Terminal deoxynucleotidyl 
transferase-mediated dUTP Nick End Labeling (TUNEL) 
method at colorectal cancer histological tissue slice (Lifshitz 
et al, 2001; Koornstra et al., 2003). 
The application of traditional medicinal plants gains more 
popularity along with Back to Nature movement including in 
Indonesia. Indonesia is the second largest country worldwide 
with the medicinal plants after Brazil thus Indonesia has big 
potential sources for the development. However, the 
disadvantages of medicinal herbs in Indonesia are lack of 
raw material standards and still have few clinical tests that 
promote the efficacy of those medicinal herbs (Adimoelja, 
2002; Mangan, 2005). One of traditional medicinal herbals 
used in Indonesia is Phyllantus niruri Linn (P. niruri L.) 
which included in Euphorbiaceae family. This plant is also 
known as meniran, meniran ijo, memeniran (Sunda) and 
gosau madungi (Malacca). Meniran is widely grown in 
Indonesia, easy in the preparation, cheap and has minimum 
side effects (Sulaksana and Jayusman, 2004). Phyllanthus 
niruri Linn riches of chemical contents including of lignans 
(phyllanthin, hypophyllanthin, nirantin, isolintetralin, 
nirphylin, phylnirurin, hynikinin, lintetralin and 
phylantostatin), flavonoids (quercetin, quercitrin, 
isoquercitrin, astragilin, rhamnopynoside, routine and 
nirurin), alkaloids, tannins, saponins, triterpenoids, resins, 
steroids, potassium, vitamin C, fatty acids and phenolic acid 
(Taylor, 2003; Bagalkotkkar et al., 2006; Markom et al., 
2007). 
The potency of P. niruri L on enhancing immune system 
modulation has been proven both in experimental animals or 
humans. Immunology test on mice proves that P. niruri L 
extract works as immune stimulator (Ma’at S, 1996). Clinical 
test on human also proves that P. niruri L extract works as 
immune modulator (Ma’at, 2010) . The role of P. niruri L 
extract on inhibiting the growth of cancer through apoptosis 
induction has not been widely explored. In-vitro test on 
cancer cell line proves that P. niruri L extract applied into 
mamma carcinoma cells culture together with C3H mice 
mononuclear can reduce the viability of those cancer cells 
(Chodidjah, 2004). Extract of P. niruri L can inhibit the 
growth of HCT116 and HT29 of human color cancer cell line 
that measured by using MTT cytotoxicity assay method 
(Sawitri, 2009). 
Based on the problem identification as described above, 
this research was conducted to study the effect of P.niruri L 
extract on the growth and development of colorectal cancer 
on Sprague-Dawley rats induced with 1,2 DMH by 
evaluating the number of apoptosis cells which expressed to 
calculate the difference of colorectal cancer apoptosis index 
between rats given by herbal and not. 
II. MATERIAL AND METHOD 
This study was an experimental research set with The 
Randomized Posttest-Only Control Group Design. Samples 
were randomly selected from affordable population consisted 
of 30 of healthy male Sprague-Dawley rats raised at 
Integrated Research and Testing Laboratory Unit IV (Pre-
Clinic) UGM, aged of 6-7 weeks with 170-220 grams weight. 
Samples were induced subcutaneously with 1,2 DMH 
30mg/kg at the first day of every week (this procedure 
followed Dani et al., 2007). At week of 9th, 11th and 13th, four 
induced rats were sacrificed at every week to be observed the 
development of colorectal cancer. At week 13th, cancer was 
found on the four rats so induction was stopped. Other 18 
rats were randomly located into two groups. The first group 
was positive control (K+) group consisted of 9 rats without 
P.niruri extract. The second group (X) was consisted of 9 
rats with the application of P.niruri L. extract.  
The extract used at this experiment was made from the 
whole part of fresh P. niruri L plant which extracted using 
maceration method with alcohol solvent 70% (ethanol). After 
passing several processes, ethanol 70% was evaporated and 
formed solid powder as the extraction result. The 
administration of extract to rats must be in solution form. P. 
niruri L extract powder was weighed as needed and then 
diluted with sterile aquades and mixed with shaker until 
reached homogenous solution. P. niruri L extract was given 
orally to rats with 13,5 mg/kg of BW per day for 30 days. 
At week 19th, all rats were terminated; colorectal tissues 
with tumor lesion were excised and processed in paraffin 
block, cut into 4 micron thickness and then made for 
histopathology preparation. The next process was 
identification of apoptosis cell using TUNEL method. 
Histopathology preparate was processed and stained with Kit 
TUNEL-IHC (Apo-BrdU-IHCTM BioVision Cat #K403). The 
evaluation of apoptosis cell was carried out by counting the 
total cells in 10 crypts column and counting the tumor cells 
with brown color using TUNEL staining (positive-TUNEL) 
at 5 visual fields under 400x magnification of light 
microscope. This method followed Kim and Park (2003). 
Counting was performed by 2 persons namely the researcher 
and Patholog with clinical agreement 95%. Apoptosis index 
was defined as the percentage of positive TUNEL cell per 
crypt column divided by the average cell per crypt column 
which counted at 10 crypts with 2 times repetitions and 
calculated the average. 
The entire processes of tissue processing and reading were 
carried out at Laboratory of Pathology Anatomy of Medical 
Faculty, UGM/RSUP dr Sardjito Yogyakarta. Data showed 
normal distribution, therefore data analysis included of 
univariate analysis and bivariate analysis. Univariate analysis 
was carried out to determine the average of each group which 
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illustrated into Boxplot graph. Bivariate analysis was carried out 
using unpaired t-test to determine the difference result due to 
treatments given to both groups. Significance level was p<0.05 
and confidence interval was 95%. 
III. RESULT AND DISCUSSION  
Apoptosis index in this research was counted from the 
number of colorectal cancer cells which positively expressed 
TUNNEL dots divided by total cells number per 
column. TUNEL staining method was used as it was very 
sensitive to apoptosis cells so it could easily distinguish cells 
experiencing apoptosis or not. The result of univariate 
analysis of apoptosis index of the two experimental groups is 
shown in Figure 1. 
Figure 1. Boxplot graph of apoptosis index of K+ and 
X group. 
Figure 1 shows the apoptosis index average of K+ 
(induced with 1,2 DMH subcoutan) was 1.45 +
apoptosis index of X group which induced with same 
carcinogens and P. niruri L extract was higher compared 
with K+ group namely 2.37 + 0.48. 
Hypotheses test to prove the application of P. niruri L 
could increase the apoptosis index was carried using 
unpaired t-test. The analysis result showed that there was 
significant different on the cells number which expressed 
TUNEL positive between K+ and X at p=0.000. TUNEL 
apoptosis cell expression on colorectal cancer cell can be 
seen on Figure 2 and 3. 
Figure 2. Apoptosis cell on K+ group. Brown color of 
apoptosis body with TUNEL staining (yellow arrow) 
between colorectal cancer cells (TUNEL staining, 400x 
magnification. 
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Figure 3. Apoptosis cell on X group. 
apoptosis body with TUNEL staining (yellow arrow) 
between colorectal cancer cells (TUNEL staining, 400x 
magnification). 
Apoptosis is also called as programmed cell death and an 
important physiological process of cell death which occurred 
without the release of intracellular matrix. The ability to 
undergo apoptosis is an important mechanism to control cells 
population and to eliminate cells experiencing DNA damage 
which cannot be repaired. This reducing ability or the 
presence of apoptosis dysregulation caused cells retention 
with the damage of DNA which in turn increased the risk of 
mutation including those with carcinogenic characteristics 
and considered as an important process in colorectal 
carcinogenesis (Crighton and  Ryan, 2004; 
Greystoke et al., 2007; Rousselot and Garnero
et al., 2009). 
This research result proved that apopto
with P.niruri L extract significantly increased compared with 
those without extract application. Thus it confirmed that 
hypothesis was accepted. This indicated that the application 
of P. niruri L extract could increase apoptosis and apopt
index could be used as a therapy response indicator towards 
colorectal cancer. P. niruri L extract could induce apoptosis 
through activating caspase-3 and producing TNF
inhibiting IL-8 expression and COX
carcinoma cell HepG2 (Sureban et al., 2006).
Detection of the apoptosis body can be done on the 
histological tissue by TUNEL method. This method was 
applied based on the assumption that genomic DNA was 
fragmented on the death cell and fragment production was 
consistent with the number of cells which 
apoptosis. Detection of fault DNA strand through the 
addition of nucleotide including deoxyuridine 
DNA fragmentation catalyzed with 
transferase with the presence of dUTP as the substrate. 
Specific painting was reacted with the addition of 
digoxigenin antibodies that brings peroxidase as conjugate 
reporter (Lifshitz et al., 2001). Morphological characteristic 
of apoptosis cell includes of plasma cell swelling, intact cell 
membrane integrity, reduced cell volume 
(dUTP) labeled with biotin at the tip of DNA fragment 
(Koornstra et al., 2003). The application of TUNEL method 
still could protect cell organ to undergo chromatin 
condensation and nucleus fragmentation to form apoptosis 
body. The apoptosis process mechanism depends on the 
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activation of caspase cascade (Huerta et al., 2006; Krysko et 
al., 2008). 
Based on the previous research and result, the researcher 
found that P. niruri L extract could improve immunology 
status and inhibit the development of colon cancer on 
experimental animals induced with 1,2 DMH. The 
improvement of immunology status was marked with the 
increasing of lymphocytes infiltration with the increasing of 
perforin secreted by NK and CTL cytotoxic lymphocytes. 
The increasing of immune competent cells improves the 
immunology status of the animals thus the antitumor cellular 
immune responses works better and ensures the occurrence 
of apoptosis on colon cancer cell (Sawitri et al., 2013). 
The ability of cytotoxic lymphocytes to initiate the 
apoptosis process on the transformed cells and kill the 
cellular target depends on two strategies of signal 
transduction that are principally different and require cell 
contact between effector and target (Yip et al., 2000; Trapani 
and Smyth. 2002). The strategy was apoptosis mechanism 
which occurred through extrinsic or intrinsic path. The 
identification of apoptosis path will give opportunity to 
understand the homeostatic control of normal colorectal 
tissue and reveal new target in colorectal cancer therapy 
(Johnstone et al., 2002; Fleischer et al., 2006). 
The apoptosis mechanism of target cells/cancer cells by 
NK and CTL cells was through two transduction signal paths. 
The first path, effector cells expresses TNF family ligan such 
as Fas/CD95 on the cell surface and used as weapon to kill 
the target cells or to destroy transformed cells which 
expresses suitable Fas receptor. Fas-ligan (FasL) is important 
in the process of eradicating tumor mediated with CTL. 
Meanwhile, TRAIL (Tumour Necrosis Factor-related 
Apoptosis-inducing Ligand) or Apo2-ligan is important to 
eliminate tumor mediated with NK cell (Yip et al., 2000; 
Screpanti et al., 2005; Grimm et al., 2010). The second path 
involves granzyme traffic mediated with perforin by 
releasing the content of cytotoxic granule (cytotoxicity 
exocytosis) which are destructive from CTL/NK to the target 
cells where they promotes death cell by 
breaking/hydrolyzing specific protein substrate including 
caspase (Yip et al., 2000; Metkar et al., 2002; Lieberman, 
2003; Bolitho et al., 2007). 
The series of complex molecular interaction indicate 
extrinsic apoptosis pathway mechanism. The bond between 
Fas death receptor with Fas ligan causes recruitment of 
FADD (Fas associated death domain) adaptor molecular and 
protease catalysator namely FLICE (Fas associated death 
domain). Death effector domain dimerization will cause 
FADD joins with procaspase 8 and forms protein complex 
named as DISC (death-inducing signalling complex) which 
activates proscaspase 8. This series of process will activate 
caspase 9 and then activate executor caspase i.e. caspase 3 
and 7 leads to the death of cancer cells in apoptosis way 
(Reed, 2003; Elmore, 2007; Yang et al., 2009).  
Apoptosis induced by perforin/granzyme (intrinsic 
pathway) is another pathway of immune system to eliminate 
transformation cells/tumor cell which conducted by NK cell 
and CTL effector cytotoxic lymphocyte. Besides of fully 
inducing apoptosis through activating apoptosis sistein 
protease (caspases) which mediated by granzyme B, this 
granule exoxitoxic pathway also activates death cell which 
not involve caspase which mediated by granzyme A to 
ensure the death of target cell (Lieberman, 2003; Bolitho et 
al., 2007; Elmore, 2007; Afonina et al., 2010).  CTL cell 
should make contact with the closest cancer cell to both 
impinge upon each other resulting in the secretion of 
cytotoxic granule content. Cytotoxic granule is a complex 
macromolecular consisted of granzyme and perforin bind 
with serglycin (proteoglycan matrix) and calreticulin (a 
perforin inhibitor) will enter into immunological synapse 
which formed between effector cell and the target. After 
exoxitosis entering space between target and effector cell, 
perforin was separated from granule complex and undergo 
polymerization so they can work separately to deliver 
granzyme-serglycin complex into the cell target through 
endocytosis (Catalfamo and Henkart, 2003; Lieberman, 2003; 
Bolitho et al., 2007). 
Intrinsic pathway is marked by the release of c 
cytochrome from mitochondria causing caspase activation. 
After it is activated, cell will undergo apoptosis. Bax 
oligomerization facilitates the opening of channel or porous 
in the outside of mitochondria thus protein inter membrane 
including of c cytochrome and other pro-apoptosis molecular 
will leave and enter into cytosol. Cytosolic c cytochrome 
mediates the development of caspase–activating complex 
named as apoptosome consisting of c cytochrome, apoptosis 
protease activating factor-1 (APAF-1) and caspases-
recruitment domains (CARD) containing of procaspase-9. 
Apoptosome will activate caspase initiator (caspase 9) and 
recruites procapase-3 which then divided and activated by 
caspase-9. This activity activates effector caspase (cascade) 
series such as caspase-3 and caspase-7 that promotes quick 
cell death. The substrate target of caspase is iCAD (inhibitor 
of DNase caspase activating deoxyribonuclease). Other 
mediator that released by mitochondria is Endonuclease-G 
(Endo-G) and apoptosis inducing factor (AIF) that would be 
trans located into nucleus and caused chromatin 
condensation, swelling cell and nucleus-DNA fragmentation 
(Watson, 2006; Elmore, 2007; Pardo et al., 2009; Yang et al., 
2009). 
Therapy that is designed to stimulate apoptosis on the 
target cell gained more important role to treat colorectal 
cancer. Medicine that directly induces apoptosis can reduce 
toxicity risk and reduce possibility of drug resistance (Reed, 
2003; Yang et al., 2009). It seems that strategy on inducing 
apoptosis will result in new safe therapy against cancer 
especially by using herbal (Johnstone et al., 2002; Fleischer 
et al., 2006). Previous researches studied the effect of 
immune modulator P.niruri L extract with the application of 
this plant’s decoction on mice BALB/c (Ma’at S, 1996) 
orally and ethanol extract orally upon Hepatitis patient 
(Ma’at, 2010). The result showed that P. niruri L extract 
stimulated immune responses both cellular and humoral 
maximally by influencing the functions and activities of 
immune-competent cells. The potency of anti-tumor and 
anti-carcinogenic of P. niruri L extract had been evaluated 
on mamma mice C3H adenokarsinoma (Chodidjah, 2004), 
hepatocellular carcinoma of Wistar rats (Rajeshkumar and 
Kuttan, 2000), sarcoma BALB/c mice and ascites tumor of 
albino Swiss mice (Rajeshkumar et al., 2002).  
This result proved that P. niruri L extract could inhibit 
the development of colorectal cancer which marked by the 
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increasing number of cancer cells experiencing apoptosis 
thus the apoptosis index in Sprague-Dawley rats increased. 
The decreasing number of colorectal tumor was due to cells 
experiencing apoptosis after the application of P. niruri L 
extract as the activity on molecular level. It was assumed that 
bioactive compound on P. niruri L extract initiated that 
activity. One of bioactive compound contained in P. niruri L 
extract is Lignan with antineoplastic characteristic 
(Giridharan et al., 2002; Wei et al., 2002) and flavonoid which 
worked as immune stimulator and antineoplastic (Erlund, 
2004; Cragg and Newman, 2005; Lakhanpal and Rai 2007; 
Cherng et al., 2008). Lignan can inhibit tolemorase and c-
myc activity thus limits cancer cell proliferation, bcl-2 and 
activates caspase 3 and caspase 8 that also induces apoptosis 
of cancer cell HepG2, EL-1 monocytes, HeLa and MCP7 cell 
lines (Giridharan et al., 2002). Flavanoid is also proved can 
inhibit proliferation and induces apoptosis on human colon 
cancer cell line of Caco-2, HT-29 (Kuntz et al., 1999) and 
SW480 (Murthy et al., 2012).   
Interruption on apoptosis mechanism significantly 
influences cancer pathogenesis. Cancer cell might inhibit 
apoptosis by failing on expressing mannose 6-phosphate 
receptor (MPR) at the cell surface (Trapani and Smyth, 
2002), excessively express serpin endogeneous such as 
granzyme B specific inhibitor of P19 (Lieberman, 2003) or 
expressing a large number of FasL at the cell surface, causes 
death of CTL and NK cell (Zimmermann and Green, 2001; 
Trapani and Smyth. 2002). Failure on the interaction 
between TCR and CTL with MHC complex class I on tumor 
causes failure on the signal transformation through cascade 
including of phosphatidylinositol 3-kinase (PI3K) pathway, a 
function needed by polarization and exocytic granule to 
release granule toxin (Catalfamo and Henkart, 2003; Bolitho 
et al., 2007).  Anti-apoptosis Bcl-2 family can also inhibit the 
release of cytochrome c leading to the failure of apoptosis 
(Reed, 2003; Watson, 2006; Yang et al., 2009). 
Many conditions may occur if apoptosis mechanism fails. 
Among others are: allows neoplastic cells to survive, gives 
chance for the accumulation of genetic disorders that 
regulate cell proliferation, interferes differentiation, promotes 
angiogenesis and increases cell motility and ability of 
malignant cell invasion during tumor progression. Defects on 
apoptosis mechanism also facilitate metastasis by allowing 
malignant epithelial cells keeps survive without being bound 
by extracellular matrix. That condition causes resistance to 
body immune system when immune competent cells such as 
CTL and NK cells rely heavily to the apoptosis machine 
integrity on fighting against tumor malignant. Therefore, 
apoptosis defects regulation is a fundamental aspect of a 
cancer biology (Koornstra et al., 2003; Watson, 2006; Elmore, 
2007; Gross and Walden, 2008). The application of P. niruri L 
extract in this research proved that herbal material which 
marked by higher apoptosis index could overcome apoptosis 
mechanism disorder against tumor progression.  
IV. CONLUSIONS 
Based on the analysis as shown in the result and 
discussion, it could be concluded that the application of P. 
niruri L extract could increase the number of cells 
experiencing apoptosis thus the colorectal cancer apoptosis 
index was higher at Sprague-Dawley rats induced with 1,2 
DMH and given by those herbal material. 
SUGGESTION 
Anti-neoplastic of P. niruri L should be more 
comprehensively understood so that it could give more 
fundamental principal for clinical test. Therefore, further 
research is necessary to be done to deeply understand anti-
cancer activity of P. niruri L extract by evaluating others 
apoptosis indicators such as ligan activity and Fas receptor, 
granzyme activity, c cytochrome expression, activity of p53 
and Bcl-2, activity of caspase initiator and executor. 
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